Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities.
Scientific Congress Publications
Supported by Bayer Pharmaceuticals
This site is a platform providing access to scientific congress publications supported by Bayer Pharmaceuticals for scientific exchange and to increase transparency of Bayer’s innovative research activities to health care professionals.
The buttons below provide access to Congress presentations across the various Therapeutic Areas. These presentations will be available for 12 months following the end of each Congress.